# Effects of High Cut-off (HCO) Hemodialysis on Central Memory CD4+ T and Treg Cells in Patients With End-stage Kidney Disease

> **NCT01103076** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Centre Hospitalier du Centre du Valais** · enrollment: 20 (estimated)

## Conditions studied

- End-stage Kidney Disease
- CD4 T Cells
- Central Memory T Cells
- Regulatory T Cells
- Uremic Toxins

## Interventions

- **DEVICE:** Polyamide HD membrane

## Key facts

- **NCT ID:** NCT01103076
- **Lead sponsor:** Centre Hospitalier du Centre du Valais
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-04
- **Primary completion:** 2011-12
- **Final completion:** 2012-02
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2011-07-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01103076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01103076, "Effects of High Cut-off (HCO) Hemodialysis on Central Memory CD4+ T and Treg Cells in Patients With End-stage Kidney Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01103076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*